Found: 27
Select item for more details and to access through your institution.
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 115, doi. 10.1007/s10637-021-01175-6
- By:
- Publication type:
- Article
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 134, doi. 10.1007/s10637-021-01170-x
- By:
- Publication type:
- Article
Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Feasibility and Acceptability of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer.
- Published in:
- Oncology Nursing Forum, 2017, v. 44, n. 5, p. 194, doi. 10.1188/17.ONF.E194-E202
- By:
- Publication type:
- Article
The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju106
- By:
- Publication type:
- Article
The Challenge to Optimize Medical Therapy for Advanced Colorectal Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1681, doi. 10.1634/theoncologist.2020-0086
- By:
- Publication type:
- Article
A Systematic Review and Network Meta‐Analysis of Regorafenib and TAS‐102 in Refractory Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1174, doi. 10.1634/theoncologist.2019-0189
- By:
- Publication type:
- Article
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 96, doi. 10.1634/theoncologist.2017-0687
- By:
- Publication type:
- Article
Outcome of Mismatch Repair‐Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1083, doi. 10.1634/theoncologist.2017-0289
- By:
- Publication type:
- Article
Systemic Therapy for Elderly Patients with Gastrointestinal Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2011, n. 5, p. 89, doi. 10.4137/CMO.S6983
- By:
- Publication type:
- Article
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920910913
- By:
- Publication type:
- Article
Treatment Selection for Younger Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 11
- By:
- Publication type:
- Article
Cases in the Management of Metastatic Colorectal Cancer: Rechallenge With Chemotherapy After Regorafenib in a Patient With RAS/BRAF Wild-Type Disease.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 2
- By:
- Publication type:
- Article
Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5778, doi. 10.3390/cancers15245778
- By:
- Publication type:
- Article
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4117, doi. 10.3390/cancers15164117
- By:
- Publication type:
- Article
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3570, doi. 10.3390/cancers15143570
- By:
- Publication type:
- Article
Comparing Oncologic Outcomes and Toxicity for Combined Modality Therapy vs. Carbon-Ion Radiotherapy for Previously Irradiated Locally Recurrent Rectal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 3057, doi. 10.3390/cancers15113057
- By:
- Publication type:
- Article
Management of Non-Colorectal Digestive Cancers with Microsatellite Instability.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 651, doi. 10.3390/cancers13040651
- By:
- Publication type:
- Article
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 12, p. 1739, doi. 10.1007/s11864-023-01142-8
- By:
- Publication type:
- Article
Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer.
- Published in:
- Case Reports in Oncological Medicine, 2015, v. 2015, p. 1, doi. 10.1155/2015/420159
- By:
- Publication type:
- Article
Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2320035, doi. 10.1001/jamanetworkopen.2023.20035
- By:
- Publication type:
- Article
Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e230400, doi. 10.1001/jamanetworkopen.2023.0400
- By:
- Publication type:
- Article
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.
- Published in:
- 2017
- By:
- Publication type:
- journal article